Sartorius | SRT3 - Sales Revenues

Stock Price
215.80
Daily Change
-3.00 -1.37%
Monthly
3.25%
Yearly
-5.35%
Q2 Forecast
211.39

Sartorius reported EUR899.1M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Sartorius EUR 899.1M 28.5M Mar/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025